Related Insights

Blog

A hybrid model supports globally diverse site participation for a retrospective cancer study

Jul 24, 2023

Article

Can Chinese Phase I data from the West accelerate China drug development?

Mar 17, 2021

Blog

Preparing for a new era in European Market Access

Jul 22, 2022

Article

Australia: The Regulatory and Reimbursement Environment

Aug 28, 2023

Article

Australia: Infrastructure and Innovations for Clinical Trials

Aug 28, 2023

Article

Australia: A highly attractive environment for drug development

Aug 24, 2023

Blog

Ensuring future success in a new market by delivering a robust safety database solution

Aug 4, 2023

Blog

Best practices and lessons learned in a challenging IBD study

Jul 19, 2023

Webinar

Assessing appropriate use of ECAs in clinical trials

May 28, 2023

Webinar

Adaptive strategies for more efficient, data-rich and patient-friendly trials

May 28, 2023

Playbook

Are you using real-world evidence?

Feb 1, 2023

Blog

Maintaining Data Integrity for Quality and Compliance – Essential Despite Pandemic Disruptions

May 16, 2022

Related Insights

Blog

A hybrid model supports globally diverse site participation for a retrospective cancer study

Jul 24, 2023

Article

Can Chinese Phase I data from the West accelerate China drug development?

Mar 17, 2021

Blog

Preparing for a new era in European Market Access

Jul 22, 2022

Article

Australia: The Regulatory and Reimbursement Environment

Aug 28, 2023

Article

Australia: Infrastructure and Innovations for Clinical Trials

Aug 28, 2023

Article

Australia: A highly attractive environment for drug development

Aug 24, 2023

Show more